Image Analysis

While many people worry that Artificial Intelligence might take away crucial jobs, it’s worth considering how the technology could revamp healthcare—particularly around detection of breast cancer, which affects millions of women around the...

Indica Labs and Xyall: Bridging the gap between histopathology and molecular pathology Albuquerque, USA and Eindhoven, The Netherlands (April 17th, 2023) – Xyall and Indica Labs have entered into a global strategic partnership designed to...

SPOKANE, Wash. and SALT LAKE CITY, April 12, 2023 /PRNewswire/ -- Gestalt Diagnostics Inc., a leading provider of Artificial Intelligence (AI)-powered digital pathology solutions, and ARUP Laboratories, a national academic reference...

Invitation from Deep Bio: Our team is ready to greet you at booth #3445! Find out how DeepDx® Prostate empowers pathologists. Also, Deep Bio will present two research abstracts in relation to biomarker in prostate and breast cancers at...

PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...

TOKYO, (April 03, 2023)— Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive...